Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Helen M Rothnie
Glucagon-Like Peptide Analogues for Type 2 Diabetes Mellitus
Related publications
Impaired Cardiometabolic Responses to Glucagon-Like Peptide 1 in Obesity and Type 2 Diabetes Mellitus
Basic Research in Cardiology
Cardiovascular Medicine
Physiology
Cardiology
Glucagon-Like Peptide-1 Analogues and Anxiety and Abnormal Eating Behaviours in Type 2 Diabetes: A Case Report
Journal of Diabetes & Metabolism
Glucagon-Like Peptide 1 Receptor Agonists: A New Approach to Type 2 Diabetes Management
South African Family Practice
Effect of Glucagon Like Peptide 1| (GLP1) Analogues on Obese Egyptians With and Without Diabetes
The Medical Journal of Cairo University
A Biological Function for Glucagon-Like Peptide-2
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Correction To: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
Clinical Drug Investigation
Medicine
Pharmacology
Review of Glucagon‐Like Peptide‐1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus in Patients With Chronic Kidney Disease and Their Renal Effects
Journal of Diabetes
Endocrinology
Metabolism
Diabetes
Patient Preferences for Frequency of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Injections in the Treatment of Type 2 Diabetes
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
In Silico Identification of Novel Glucagon Receptor Antagonist for the Treatment of Type 2 Diabetes Mellitus
Enzyme Engineering
